Skip to main content
OpenTrials
Completed

NCT Number: NCT00335803

A Research Study To Compare Two Kinds Of Daily Headache

Chronic daily headache has been classified into several categories. One category is of sudden onset and is called New Daily Persistent Headache (NDPH). Another category of daily headache evolves gradually and is called Transformed Migraine (TM). This research study is being conducted to compare people with these two kinds of daily headache in order to improve our understanding of these conditions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Jefferson Headache Center

Philadelphia, Pennsylvania, 19107, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female patients aged 14-65, inclusive
  • Diagnosis of NDPH or TM according to the Silberstein-Lipton criteria.
  • Ability to read and understand an informed consent form and study procedures

Exclusion criteria

  • Pregnancy
  • Subjects with any disease or condition that would result in unreliable data or confound the data obtained for this study, as determined by the principal investigator.

Sponsors and collaborators

Lead sponsor

Thomas Jefferson University

Other

Registry information

Official study title

A Comparison Of Subjects With New Daily Persistent Headache (NDPH) And Subjects With Transformed Migraine (TM)

Important dates

Study start
2006
Study completion
2007
First posted
Jun 12, 2006
Registry last updated
Jan 23, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.